Ken Iseri

793 total citations
38 papers, 576 citations indexed

About

Ken Iseri is a scholar working on Nephrology, Orthopedics and Sports Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ken Iseri has authored 38 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 12 papers in Orthopedics and Sports Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ken Iseri's work include Bone health and treatments (8 papers), Parathyroid Disorders and Treatments (8 papers) and Bone and Joint Diseases (8 papers). Ken Iseri is often cited by papers focused on Bone health and treatments (8 papers), Parathyroid Disorders and Treatments (8 papers) and Bone and Joint Diseases (8 papers). Ken Iseri collaborates with scholars based in Japan, Sweden and United Kingdom. Ken Iseri's co-authors include Takanori Shibata, Masayuki Iyoda, Kei Matsumoto, Yukihiro Wada, Abdul Rashid Qureshi, Taihei Suzuki, Bengt Lindholm, Tomohiro Saito, Peter Stenvinkel and Makoto Watanabe and has published in prestigious journals such as PLoS ONE, Journal of Bone and Mineral Research and Bone.

In The Last Decade

Ken Iseri

35 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Iseri Japan 15 327 191 142 104 89 38 576
Diana M. Antoniucci United States 13 344 1.1× 140 0.7× 129 0.9× 118 1.1× 258 2.9× 15 728
Fabiana G. Graciolli Brazil 12 792 2.4× 98 0.5× 96 0.7× 111 1.1× 225 2.5× 19 896
Lobna R. Ezz El Arab Egypt 9 296 0.9× 146 0.8× 112 0.8× 75 0.7× 78 0.9× 23 534
Syazrah Salam United Kingdom 11 395 1.2× 349 1.8× 220 1.5× 72 0.7× 103 1.2× 16 688
Maria L. Mace Denmark 16 339 1.0× 47 0.2× 46 0.3× 131 1.3× 82 0.9× 27 592
Kátia R. Neves Brazil 12 991 3.0× 193 1.0× 172 1.2× 102 1.0× 263 3.0× 15 1.1k
Micaela Manni Italy 16 711 2.2× 216 1.1× 196 1.4× 96 0.9× 234 2.6× 28 899
Claudia Fofi Italy 9 209 0.6× 38 0.2× 54 0.4× 98 0.9× 36 0.4× 21 447
Evelyn Alonzo Venezuela 9 130 0.4× 98 0.5× 78 0.5× 64 0.6× 46 0.5× 10 360
J L Barron United Kingdom 13 188 0.6× 52 0.3× 66 0.5× 53 0.5× 60 0.7× 29 494

Countries citing papers authored by Ken Iseri

Since Specialization
Citations

This map shows the geographic impact of Ken Iseri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Iseri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Iseri more than expected).

Fields of papers citing papers by Ken Iseri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Iseri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Iseri. The network helps show where Ken Iseri may publish in the future.

Co-authorship network of co-authors of Ken Iseri

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Iseri. A scholar is included among the top collaborators of Ken Iseri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Iseri. Ken Iseri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iseri, Ken, et al.. (2024). Risk factors for osteonecrosis of the jaw in patients with chronic kidney disease: a nested case-control study. Journal of Bone and Mineral Research. 40(2). 262–269.
3.
Witasp, Anna, Louise Nordfors, Abdul Rashid Qureshi, et al.. (2023). Epigenetic clocks indicate that kidney transplantation and not dialysis mitigate the effects of renal ageing. Journal of Internal Medicine. 295(1). 79–90. 15 indexed citations
4.
Iseri, Ken, et al.. (2023). Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients. Nephrology Dialysis Transplantation. 39(6). 1016–1022. 12 indexed citations
6.
Iseri, Ken, et al.. (2022). Bilateral renal subcapsular hematoma caused by polyarteritis nodosa: a case report. CEN Case Reports. 11(4). 399–403. 4 indexed citations
7.
Iseri, Ken, Juan Jesús Carrero, Marie Evans, et al.. (2021). Secular trends in hip fracture incidence and subsequent mortality in dialysis patients and the general population in Sweden. Bone. 147. 115909–115909. 9 indexed citations
8.
Iyoda, Masayuki, Kei Matsumoto, Yukihiro Wada, et al.. (2020). Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto Rats. Kidney & Blood Pressure Research. 45(3). 391–406. 3 indexed citations
9.
Iseri, Ken, Juan Jesús Carrero, Marie Evans, et al.. (2020). Major fractures after initiation of dialysis: Incidence, predictors and association with mortality. Bone. 133. 115242–115242. 16 indexed citations
10.
Iseri, Ken, Abdul Rashid Qureshi, Jonaz Ripsweden, et al.. (2020). Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality. Journal of Bone and Mineral Metabolism. 39(2). 260–269. 6 indexed citations
11.
Iseri, Ken, Juan Jesús Carrero, Marie Evans, et al.. (2020). Fractures after kidney transplantation: Incidence, predictors, and association with mortality. Bone. 140. 115554–115554. 24 indexed citations
12.
Iseri, Ken, Juan Jesús Carrero, Marie Evans, et al.. (2020). Incidence of Fractures Before and After Dialysis Initiation. Journal of Bone and Mineral Research. 35(12). 2372–2380. 8 indexed citations
13.
Iseri, Ken, Juan Jesús Carrero, Marie Evans, et al.. (2020). P1389MAJOR OSTEOPOROTIC FRACTURES AFTER INITIATION OF DIALYSIS: INCIDENCE, PREDICTORS AND ASSOCIATION WITH MORTALITY. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
14.
Iseri, Ken, Abdul Rashid Qureshi, Lu Dai, et al.. (2019). Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study. Bone. 130. 115075–115075. 22 indexed citations
15.
Iseri, Ken, et al.. (2019). Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial. Journal of Bone and Mineral Research. 34(6). 1014–1024. 76 indexed citations
16.
Iseri, Ken, Makoto Watanabe, Xiao‐Pen Lee, et al.. (2019). Elimination of intravenous alendronate by hemodialysis: A kinetic study. Hemodialysis International. 23(4). 466–471. 6 indexed citations
17.
Wada, Yukihiro, Kei Matsumoto, Taihei Suzuki, et al.. (2018). Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS ONE. 13(11). e0206865–e0206865. 52 indexed citations
18.
Yamada, Miho, Xiao‐Pen Lee, Ken Iseri, et al.. (2017). Highly sensitive determination of alendronate in human plasma and dialysate using metal-free HPLC-MS/MS. Legal Medicine. 30. 14–20. 14 indexed citations
19.
Iyoda, Masayuki, Ken Iseri, Tomohiro Saito, et al.. (2016). Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. PLoS ONE. 11(6). e0158154–e0158154. 48 indexed citations
20.
Wada, Yukihiro, Masayuki Iyoda, Kei Matsumoto, et al.. (2014). Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats. PLoS ONE. 9(11). e111728–e111728. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026